Abstract:STAT3 is a key transcription factor that can mediate cancer progression through phosphorylation or gain-of-function mutations. STAT3 mutations have been mainly associated with large granular lymphocytic T-cell leukemia. Whereas STAT3 activation is common in myeloid neoplasms, it is primarily mediated through STAT3 phosphorylation. STAT3 mutation has only rarely been reported in myeloid neoplasms. We assessed the clinicopathologic and molecular genetic features of 32 STAT3-mutated myeloid neoplasms. Twenty (62.5%) cases were classified as acute myeloid leukemia (AML), 7 (21.9%) as myelodysplastic syndrome (MDS), and 5 (15.6%) as chronic myelomonocytic leukemia (CMML). It is of note that STAT3 mutation was not detected in myeloproliferative neoplasms (MPN). STAT3 mutations were detected at the initial diagnosis in 22 of 25 (88%) cases, suggesting STAT3 mutation is an early event in pathogenesis. However, STAT3 mutations represented the dominant clone in only 6 (18.8%) cases, all classified as AML. Most are missense mutations, located at the SH2 domain. The median variant allele frequencies were 6.8%, 4.6% and 3.1% for AML, MDS and CMML, respectively, and in a case of CMML, the VAF increased from 2.4% to 34.8% upon leukemic transformation. STAT3 mutation was accompanied by co-existing mutations in all cases, with SRSF2 (40.6%), TET2 (40.6%), ASXL1 (37.5%), and SETBP1 (34.4%) being most common. Cases with STAT3 mutations were usually associated with morphologic dysplasia and increased blasts. Monosomy 7/del7q was the most common cytogenetic abnormality, seen in 11 (34.4%) cases. With a median follow-up of 24.5 months, 21 patients died, 6 had persistent disease, and 5 achieved complete remission. We summarize that STAT3 mutation is present in a variety of myeloid neoplasms, but not seen in MPN. It is often an early events and always with concurrent mutations. It may play an important role in the pathogenesis and progression of myeloid neoplasms by activating JAK-STAT pathway, and may serve as a potential therapeutic target. Citation Format: Matthew T. Ye, Zhuang Zuo, Steliana Calin, Fengxi Ye, Hua He, Wataru Kamata, M. James You. Clinicopathologic and molecular genetic features of STAT3-mutated myeloid neoplasms [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5053.

The characteristics of clinical manifestations, gene mutations and B lymphocytes differentiation of AD-HIES Children

The Clinical, Immunological and Genetic Features of 12 Chinese Patients with STAT3 Mutations

Clinical significance and prognostic value of STAT 3 expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

Clinicopathologic Significance of MYD88 L265P Mutation and Expression of TLR4 and P-STAT3 in Primary Central Nervous System Diffuse Large B-cell Lymphomas

Defective Toll-Like Receptors Driven B Cell Response in Hyper IgE Syndrome Patients With <i>STAT3</i> Mutations

Analysis of Clinical Manifestations of 43 Children with Langerhans Cell Histiocytosis at Diagnosis

Defective Toll-Like Receptors Driven B Cell Response in Hyper IgE Syndrome Patients With STAT3 Mutations

[Expression and Clinical Significance of STAT3 Genes in Patients with Acute Myeloid Leukemia].

A study on T - cell subgroup in peripheral blood of children with aplastic anemia

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia

Clinical and Genetic Characteristics of <i>IKZF1</i> Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia

[A Genetic Analysis of Children with Epstein-Barr Virus-Positive Hemophagocytic Lymphohistiocytosis and Its Association with T-helper Type 1/T-Helper Type 2 Cytokines].

Biologic Features of 403 Pediatric Leukemia in Children's Hospital in Zhejiang Province in East China

STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model

Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review

STAT3 in regulating Th17 differentiation and its relationship with autoimmune hematological diseases

Genetic Polymorphisms of STAT3 Correlated with Prognosis in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab.

Clonality Analysis and Mutational Status of IgVH Gene in Hodgkin Variant of Richter Syndrome

[Variation of STAT3 Gene in Myleproliferative Neoplasms and Its Significance].

Abstract 5053: Clinicopathologic and molecular genetic features of STAT3-mutated myeloid neoplasms

Integrated Clinical Genotype-phenotype Characteristics of STAT3-mutated Myeloid Neoplasms